Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
342
archived clinical trials in
Postherpatic Neuralgia

Analgesic Efficacy and Safety of V116517 in Subjects With Moderate to Severe Chronic Pain Due to Postherpetic Neuralgia (PHN)
A Phase 2, Randomized, Double-blind, Placebo- and Active-controlled, Parallel-group, Multicenter Study Evaluating the Analgesic Efficacy and Safety of V116517 in Subjects With Moderate to Severe Chronic Pain Due to Postherpetic Neuralgia (PHN)
Status: Enrolling
Updated:  9/12/2013
mi
from
Austin, TX
Analgesic Efficacy and Safety of V116517 in Subjects With Moderate to Severe Chronic Pain Due to Postherpetic Neuralgia (PHN)
A Phase 2, Randomized, Double-blind, Placebo- and Active-controlled, Parallel-group, Multicenter Study Evaluating the Analgesic Efficacy and Safety of V116517 in Subjects With Moderate to Severe Chronic Pain Due to Postherpetic Neuralgia (PHN)
Status: Enrolling
Updated: 9/12/2013
Clinical Research Facility
mi
from
Austin, TX
Click here to add this to my saved trials
Analgesic Efficacy and Safety of V116517 in Subjects With Moderate to Severe Chronic Pain Due to Postherpetic Neuralgia (PHN)
A Phase 2, Randomized, Double-blind, Placebo- and Active-controlled, Parallel-group, Multicenter Study Evaluating the Analgesic Efficacy and Safety of V116517 in Subjects With Moderate to Severe Chronic Pain Due to Postherpetic Neuralgia (PHN)
Status: Enrolling
Updated:  9/12/2013
mi
from
Salt Lake City, UT
Analgesic Efficacy and Safety of V116517 in Subjects With Moderate to Severe Chronic Pain Due to Postherpetic Neuralgia (PHN)
A Phase 2, Randomized, Double-blind, Placebo- and Active-controlled, Parallel-group, Multicenter Study Evaluating the Analgesic Efficacy and Safety of V116517 in Subjects With Moderate to Severe Chronic Pain Due to Postherpetic Neuralgia (PHN)
Status: Enrolling
Updated: 9/12/2013
Clinical Research Facility
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
Efficacy, Tolerability, and Safety of NXN-462 in Patients With Post-Herpetic Neuralgia
A Double-Blind, Randomized, Placebo-Controlled, Parallel Group Study to Evaluate the Efficacy, Tolerability, and Safety of NXN-462 in Patients With Post-Herpetic Neuralgia (PHN)
Status: Enrolling
Updated:  12/31/2013
mi
from
Phoenix, AZ
Efficacy, Tolerability, and Safety of NXN-462 in Patients With Post-Herpetic Neuralgia
A Double-Blind, Randomized, Placebo-Controlled, Parallel Group Study to Evaluate the Efficacy, Tolerability, and Safety of NXN-462 in Patients With Post-Herpetic Neuralgia (PHN)
Status: Enrolling
Updated: 12/31/2013
Premier Research
mi
from
Phoenix, AZ
Click here to add this to my saved trials
Efficacy, Tolerability, and Safety of NXN-462 in Patients With Post-Herpetic Neuralgia
A Double-Blind, Randomized, Placebo-Controlled, Parallel Group Study to Evaluate the Efficacy, Tolerability, and Safety of NXN-462 in Patients With Post-Herpetic Neuralgia (PHN)
Status: Enrolling
Updated:  12/31/2013
mi
from
Los Angeles, CA
Efficacy, Tolerability, and Safety of NXN-462 in Patients With Post-Herpetic Neuralgia
A Double-Blind, Randomized, Placebo-Controlled, Parallel Group Study to Evaluate the Efficacy, Tolerability, and Safety of NXN-462 in Patients With Post-Herpetic Neuralgia (PHN)
Status: Enrolling
Updated: 12/31/2013
University of Southern California
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Efficacy, Tolerability, and Safety of NXN-462 in Patients With Post-Herpetic Neuralgia
A Double-Blind, Randomized, Placebo-Controlled, Parallel Group Study to Evaluate the Efficacy, Tolerability, and Safety of NXN-462 in Patients With Post-Herpetic Neuralgia (PHN)
Status: Enrolling
Updated:  12/31/2013
mi
from
Napa, CA
Efficacy, Tolerability, and Safety of NXN-462 in Patients With Post-Herpetic Neuralgia
A Double-Blind, Randomized, Placebo-Controlled, Parallel Group Study to Evaluate the Efficacy, Tolerability, and Safety of NXN-462 in Patients With Post-Herpetic Neuralgia (PHN)
Status: Enrolling
Updated: 12/31/2013
Neurovations
mi
from
Napa, CA
Click here to add this to my saved trials
Efficacy, Tolerability, and Safety of NXN-462 in Patients With Post-Herpetic Neuralgia
A Double-Blind, Randomized, Placebo-Controlled, Parallel Group Study to Evaluate the Efficacy, Tolerability, and Safety of NXN-462 in Patients With Post-Herpetic Neuralgia (PHN)
Status: Enrolling
Updated:  12/31/2013
mi
from
Sacramento, CA
Efficacy, Tolerability, and Safety of NXN-462 in Patients With Post-Herpetic Neuralgia
A Double-Blind, Randomized, Placebo-Controlled, Parallel Group Study to Evaluate the Efficacy, Tolerability, and Safety of NXN-462 in Patients With Post-Herpetic Neuralgia (PHN)
Status: Enrolling
Updated: 12/31/2013
Northern California Research
mi
from
Sacramento, CA
Click here to add this to my saved trials
Efficacy, Tolerability, and Safety of NXN-462 in Patients With Post-Herpetic Neuralgia
A Double-Blind, Randomized, Placebo-Controlled, Parallel Group Study to Evaluate the Efficacy, Tolerability, and Safety of NXN-462 in Patients With Post-Herpetic Neuralgia (PHN)
Status: Enrolling
Updated:  12/31/2013
mi
from
Santa Monica, CA
Efficacy, Tolerability, and Safety of NXN-462 in Patients With Post-Herpetic Neuralgia
A Double-Blind, Randomized, Placebo-Controlled, Parallel Group Study to Evaluate the Efficacy, Tolerability, and Safety of NXN-462 in Patients With Post-Herpetic Neuralgia (PHN)
Status: Enrolling
Updated: 12/31/2013
Neurological Research Institute
mi
from
Santa Monica, CA
Click here to add this to my saved trials
Efficacy, Tolerability, and Safety of NXN-462 in Patients With Post-Herpetic Neuralgia
A Double-Blind, Randomized, Placebo-Controlled, Parallel Group Study to Evaluate the Efficacy, Tolerability, and Safety of NXN-462 in Patients With Post-Herpetic Neuralgia (PHN)
Status: Enrolling
Updated:  12/31/2013
mi
from
Brooksville, FL
Efficacy, Tolerability, and Safety of NXN-462 in Patients With Post-Herpetic Neuralgia
A Double-Blind, Randomized, Placebo-Controlled, Parallel Group Study to Evaluate the Efficacy, Tolerability, and Safety of NXN-462 in Patients With Post-Herpetic Neuralgia (PHN)
Status: Enrolling
Updated: 12/31/2013
Meridien Research
mi
from
Brooksville, FL
Click here to add this to my saved trials
Efficacy, Tolerability, and Safety of NXN-462 in Patients With Post-Herpetic Neuralgia
A Double-Blind, Randomized, Placebo-Controlled, Parallel Group Study to Evaluate the Efficacy, Tolerability, and Safety of NXN-462 in Patients With Post-Herpetic Neuralgia (PHN)
Status: Enrolling
Updated:  12/31/2013
mi
from
Kissimmee, FL
Efficacy, Tolerability, and Safety of NXN-462 in Patients With Post-Herpetic Neuralgia
A Double-Blind, Randomized, Placebo-Controlled, Parallel Group Study to Evaluate the Efficacy, Tolerability, and Safety of NXN-462 in Patients With Post-Herpetic Neuralgia (PHN)
Status: Enrolling
Updated: 12/31/2013
Fpa Clinical Research
mi
from
Kissimmee, FL
Click here to add this to my saved trials
Efficacy, Tolerability, and Safety of NXN-462 in Patients With Post-Herpetic Neuralgia
A Double-Blind, Randomized, Placebo-Controlled, Parallel Group Study to Evaluate the Efficacy, Tolerability, and Safety of NXN-462 in Patients With Post-Herpetic Neuralgia (PHN)
Status: Enrolling
Updated:  12/31/2013
mi
from
New Port Richey, FL
Efficacy, Tolerability, and Safety of NXN-462 in Patients With Post-Herpetic Neuralgia
A Double-Blind, Randomized, Placebo-Controlled, Parallel Group Study to Evaluate the Efficacy, Tolerability, and Safety of NXN-462 in Patients With Post-Herpetic Neuralgia (PHN)
Status: Enrolling
Updated: 12/31/2013
Suncoast Clinical Research, Inc.
mi
from
New Port Richey, FL
Click here to add this to my saved trials
Efficacy, Tolerability, and Safety of NXN-462 in Patients With Post-Herpetic Neuralgia
A Double-Blind, Randomized, Placebo-Controlled, Parallel Group Study to Evaluate the Efficacy, Tolerability, and Safety of NXN-462 in Patients With Post-Herpetic Neuralgia (PHN)
Status: Enrolling
Updated:  12/31/2013
mi
from
Orlando, FL
Efficacy, Tolerability, and Safety of NXN-462 in Patients With Post-Herpetic Neuralgia
A Double-Blind, Randomized, Placebo-Controlled, Parallel Group Study to Evaluate the Efficacy, Tolerability, and Safety of NXN-462 in Patients With Post-Herpetic Neuralgia (PHN)
Status: Enrolling
Updated: 12/31/2013
Compass Research LLC
mi
from
Orlando, FL
Click here to add this to my saved trials
Efficacy, Tolerability, and Safety of NXN-462 in Patients With Post-Herpetic Neuralgia
A Double-Blind, Randomized, Placebo-Controlled, Parallel Group Study to Evaluate the Efficacy, Tolerability, and Safety of NXN-462 in Patients With Post-Herpetic Neuralgia (PHN)
Status: Enrolling
Updated:  12/31/2013
mi
from
Sarasota, FL
Efficacy, Tolerability, and Safety of NXN-462 in Patients With Post-Herpetic Neuralgia
A Double-Blind, Randomized, Placebo-Controlled, Parallel Group Study to Evaluate the Efficacy, Tolerability, and Safety of NXN-462 in Patients With Post-Herpetic Neuralgia (PHN)
Status: Enrolling
Updated: 12/31/2013
Sarasota Pain Medicine Research
mi
from
Sarasota, FL
Click here to add this to my saved trials
Efficacy, Tolerability, and Safety of NXN-462 in Patients With Post-Herpetic Neuralgia
A Double-Blind, Randomized, Placebo-Controlled, Parallel Group Study to Evaluate the Efficacy, Tolerability, and Safety of NXN-462 in Patients With Post-Herpetic Neuralgia (PHN)
Status: Enrolling
Updated:  12/31/2013
mi
from
Tampa, FL
Efficacy, Tolerability, and Safety of NXN-462 in Patients With Post-Herpetic Neuralgia
A Double-Blind, Randomized, Placebo-Controlled, Parallel Group Study to Evaluate the Efficacy, Tolerability, and Safety of NXN-462 in Patients With Post-Herpetic Neuralgia (PHN)
Status: Enrolling
Updated: 12/31/2013
Meridien Research
mi
from
Tampa, FL
Click here to add this to my saved trials
Efficacy, Tolerability, and Safety of NXN-462 in Patients With Post-Herpetic Neuralgia
A Double-Blind, Randomized, Placebo-Controlled, Parallel Group Study to Evaluate the Efficacy, Tolerability, and Safety of NXN-462 in Patients With Post-Herpetic Neuralgia (PHN)
Status: Enrolling
Updated:  12/31/2013
mi
from
Decatur, GA
Efficacy, Tolerability, and Safety of NXN-462 in Patients With Post-Herpetic Neuralgia
A Double-Blind, Randomized, Placebo-Controlled, Parallel Group Study to Evaluate the Efficacy, Tolerability, and Safety of NXN-462 in Patients With Post-Herpetic Neuralgia (PHN)
Status: Enrolling
Updated: 12/31/2013
Dekalb Neurology Associates, LLC
mi
from
Decatur, GA
Click here to add this to my saved trials
Efficacy, Tolerability, and Safety of NXN-462 in Patients With Post-Herpetic Neuralgia
A Double-Blind, Randomized, Placebo-Controlled, Parallel Group Study to Evaluate the Efficacy, Tolerability, and Safety of NXN-462 in Patients With Post-Herpetic Neuralgia (PHN)
Status: Enrolling
Updated:  12/31/2013
mi
from
Chicago, IL
Efficacy, Tolerability, and Safety of NXN-462 in Patients With Post-Herpetic Neuralgia
A Double-Blind, Randomized, Placebo-Controlled, Parallel Group Study to Evaluate the Efficacy, Tolerability, and Safety of NXN-462 in Patients With Post-Herpetic Neuralgia (PHN)
Status: Enrolling
Updated: 12/31/2013
Medex Healthcare Research, Inc.
mi
from
Chicago, IL
Click here to add this to my saved trials
Efficacy, Tolerability, and Safety of NXN-462 in Patients With Post-Herpetic Neuralgia
A Double-Blind, Randomized, Placebo-Controlled, Parallel Group Study to Evaluate the Efficacy, Tolerability, and Safety of NXN-462 in Patients With Post-Herpetic Neuralgia (PHN)
Status: Enrolling
Updated:  12/31/2013
mi
from
West Des Moines, IA
Efficacy, Tolerability, and Safety of NXN-462 in Patients With Post-Herpetic Neuralgia
A Double-Blind, Randomized, Placebo-Controlled, Parallel Group Study to Evaluate the Efficacy, Tolerability, and Safety of NXN-462 in Patients With Post-Herpetic Neuralgia (PHN)
Status: Enrolling
Updated: 12/31/2013
Integrated Clinical Trial Services, Inc.
mi
from
West Des Moines, IA
Click here to add this to my saved trials
Efficacy, Tolerability, and Safety of NXN-462 in Patients With Post-Herpetic Neuralgia
A Double-Blind, Randomized, Placebo-Controlled, Parallel Group Study to Evaluate the Efficacy, Tolerability, and Safety of NXN-462 in Patients With Post-Herpetic Neuralgia (PHN)
Status: Enrolling
Updated:  12/31/2013
mi
from
Towson, MD
Efficacy, Tolerability, and Safety of NXN-462 in Patients With Post-Herpetic Neuralgia
A Double-Blind, Randomized, Placebo-Controlled, Parallel Group Study to Evaluate the Efficacy, Tolerability, and Safety of NXN-462 in Patients With Post-Herpetic Neuralgia (PHN)
Status: Enrolling
Updated: 12/31/2013
IRC Clinics, Inc.
mi
from
Towson, MD
Click here to add this to my saved trials
Efficacy, Tolerability, and Safety of NXN-462 in Patients With Post-Herpetic Neuralgia
A Double-Blind, Randomized, Placebo-Controlled, Parallel Group Study to Evaluate the Efficacy, Tolerability, and Safety of NXN-462 in Patients With Post-Herpetic Neuralgia (PHN)
Status: Enrolling
Updated:  12/31/2013
mi
from
Boston, MA
Efficacy, Tolerability, and Safety of NXN-462 in Patients With Post-Herpetic Neuralgia
A Double-Blind, Randomized, Placebo-Controlled, Parallel Group Study to Evaluate the Efficacy, Tolerability, and Safety of NXN-462 in Patients With Post-Herpetic Neuralgia (PHN)
Status: Enrolling
Updated: 12/31/2013
Boston Clinical Trials, INC.
mi
from
Boston, MA
Click here to add this to my saved trials
Efficacy, Tolerability, and Safety of NXN-462 in Patients With Post-Herpetic Neuralgia
A Double-Blind, Randomized, Placebo-Controlled, Parallel Group Study to Evaluate the Efficacy, Tolerability, and Safety of NXN-462 in Patients With Post-Herpetic Neuralgia (PHN)
Status: Enrolling
Updated:  12/31/2013
mi
from
Ann Arbor, MI
Efficacy, Tolerability, and Safety of NXN-462 in Patients With Post-Herpetic Neuralgia
A Double-Blind, Randomized, Placebo-Controlled, Parallel Group Study to Evaluate the Efficacy, Tolerability, and Safety of NXN-462 in Patients With Post-Herpetic Neuralgia (PHN)
Status: Enrolling
Updated: 12/31/2013
Michigan Head Pain & Neurological Institute
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
Efficacy, Tolerability, and Safety of NXN-462 in Patients With Post-Herpetic Neuralgia
A Double-Blind, Randomized, Placebo-Controlled, Parallel Group Study to Evaluate the Efficacy, Tolerability, and Safety of NXN-462 in Patients With Post-Herpetic Neuralgia (PHN)
Status: Enrolling
Updated:  12/31/2013
mi
from
Albuquerque, NM
Efficacy, Tolerability, and Safety of NXN-462 in Patients With Post-Herpetic Neuralgia
A Double-Blind, Randomized, Placebo-Controlled, Parallel Group Study to Evaluate the Efficacy, Tolerability, and Safety of NXN-462 in Patients With Post-Herpetic Neuralgia (PHN)
Status: Enrolling
Updated: 12/31/2013
Albuquerque Clinical Trials
mi
from
Albuquerque, NM
Click here to add this to my saved trials
Efficacy, Tolerability, and Safety of NXN-462 in Patients With Post-Herpetic Neuralgia
A Double-Blind, Randomized, Placebo-Controlled, Parallel Group Study to Evaluate the Efficacy, Tolerability, and Safety of NXN-462 in Patients With Post-Herpetic Neuralgia (PHN)
Status: Enrolling
Updated:  12/31/2013
mi
from
Hickory, NC
Efficacy, Tolerability, and Safety of NXN-462 in Patients With Post-Herpetic Neuralgia
A Double-Blind, Randomized, Placebo-Controlled, Parallel Group Study to Evaluate the Efficacy, Tolerability, and Safety of NXN-462 in Patients With Post-Herpetic Neuralgia (PHN)
Status: Enrolling
Updated: 12/31/2013
Clinical Trials of America Inc
mi
from
Hickory, NC
Click here to add this to my saved trials
Efficacy, Tolerability, and Safety of NXN-462 in Patients With Post-Herpetic Neuralgia
A Double-Blind, Randomized, Placebo-Controlled, Parallel Group Study to Evaluate the Efficacy, Tolerability, and Safety of NXN-462 in Patients With Post-Herpetic Neuralgia (PHN)
Status: Enrolling
Updated:  12/31/2013
mi
from
Raleigh, NC
Efficacy, Tolerability, and Safety of NXN-462 in Patients With Post-Herpetic Neuralgia
A Double-Blind, Randomized, Placebo-Controlled, Parallel Group Study to Evaluate the Efficacy, Tolerability, and Safety of NXN-462 in Patients With Post-Herpetic Neuralgia (PHN)
Status: Enrolling
Updated: 12/31/2013
Wake Research Associates, LLC
mi
from
Raleigh, NC
Click here to add this to my saved trials
Efficacy, Tolerability, and Safety of NXN-462 in Patients With Post-Herpetic Neuralgia
A Double-Blind, Randomized, Placebo-Controlled, Parallel Group Study to Evaluate the Efficacy, Tolerability, and Safety of NXN-462 in Patients With Post-Herpetic Neuralgia (PHN)
Status: Enrolling
Updated:  12/31/2013
mi
from
Oklahoma City, OK
Efficacy, Tolerability, and Safety of NXN-462 in Patients With Post-Herpetic Neuralgia
A Double-Blind, Randomized, Placebo-Controlled, Parallel Group Study to Evaluate the Efficacy, Tolerability, and Safety of NXN-462 in Patients With Post-Herpetic Neuralgia (PHN)
Status: Enrolling
Updated: 12/31/2013
Lynn Health Science Institute
mi
from
Oklahoma City, OK
Click here to add this to my saved trials
Efficacy, Tolerability, and Safety of NXN-462 in Patients With Post-Herpetic Neuralgia
A Double-Blind, Randomized, Placebo-Controlled, Parallel Group Study to Evaluate the Efficacy, Tolerability, and Safety of NXN-462 in Patients With Post-Herpetic Neuralgia (PHN)
Status: Enrolling
Updated:  12/31/2013
mi
from
Mt. Pleasant, SC
Efficacy, Tolerability, and Safety of NXN-462 in Patients With Post-Herpetic Neuralgia
A Double-Blind, Randomized, Placebo-Controlled, Parallel Group Study to Evaluate the Efficacy, Tolerability, and Safety of NXN-462 in Patients With Post-Herpetic Neuralgia (PHN)
Status: Enrolling
Updated: 12/31/2013
Pain Specialist of Charleston, P.A.
mi
from
Mt. Pleasant, SC
Click here to add this to my saved trials
Efficacy, Tolerability, and Safety of NXN-462 in Patients With Post-Herpetic Neuralgia
A Double-Blind, Randomized, Placebo-Controlled, Parallel Group Study to Evaluate the Efficacy, Tolerability, and Safety of NXN-462 in Patients With Post-Herpetic Neuralgia (PHN)
Status: Enrolling
Updated:  12/31/2013
mi
from
Nashville, TN
Efficacy, Tolerability, and Safety of NXN-462 in Patients With Post-Herpetic Neuralgia
A Double-Blind, Randomized, Placebo-Controlled, Parallel Group Study to Evaluate the Efficacy, Tolerability, and Safety of NXN-462 in Patients With Post-Herpetic Neuralgia (PHN)
Status: Enrolling
Updated: 12/31/2013
Nashville Neuroscience Group, PC
mi
from
Nashville, TN
Click here to add this to my saved trials
Efficacy, Tolerability, and Safety of NXN-462 in Patients With Post-Herpetic Neuralgia
A Double-Blind, Randomized, Placebo-Controlled, Parallel Group Study to Evaluate the Efficacy, Tolerability, and Safety of NXN-462 in Patients With Post-Herpetic Neuralgia (PHN)
Status: Enrolling
Updated:  12/31/2013
mi
from
Tullahoma, TN
Efficacy, Tolerability, and Safety of NXN-462 in Patients With Post-Herpetic Neuralgia
A Double-Blind, Randomized, Placebo-Controlled, Parallel Group Study to Evaluate the Efficacy, Tolerability, and Safety of NXN-462 in Patients With Post-Herpetic Neuralgia (PHN)
Status: Enrolling
Updated: 12/31/2013
Trinity Clinical Research
mi
from
Tullahoma, TN
Click here to add this to my saved trials
Efficacy, Tolerability, and Safety of NXN-462 in Patients With Post-Herpetic Neuralgia
A Double-Blind, Randomized, Placebo-Controlled, Parallel Group Study to Evaluate the Efficacy, Tolerability, and Safety of NXN-462 in Patients With Post-Herpetic Neuralgia (PHN)
Status: Enrolling
Updated:  12/31/2013
mi
from
Plano, TX
Efficacy, Tolerability, and Safety of NXN-462 in Patients With Post-Herpetic Neuralgia
A Double-Blind, Randomized, Placebo-Controlled, Parallel Group Study to Evaluate the Efficacy, Tolerability, and Safety of NXN-462 in Patients With Post-Herpetic Neuralgia (PHN)
Status: Enrolling
Updated: 12/31/2013
ClinRx Research LLC
mi
from
Plano, TX
Click here to add this to my saved trials
Efficacy, Tolerability, and Safety of NXN-462 in Patients With Post-Herpetic Neuralgia
A Double-Blind, Randomized, Placebo-Controlled, Parallel Group Study to Evaluate the Efficacy, Tolerability, and Safety of NXN-462 in Patients With Post-Herpetic Neuralgia (PHN)
Status: Enrolling
Updated:  12/31/2013
mi
from
San Antonio, TX
Efficacy, Tolerability, and Safety of NXN-462 in Patients With Post-Herpetic Neuralgia
A Double-Blind, Randomized, Placebo-Controlled, Parallel Group Study to Evaluate the Efficacy, Tolerability, and Safety of NXN-462 in Patients With Post-Herpetic Neuralgia (PHN)
Status: Enrolling
Updated: 12/31/2013
Progressive Clinical Research
mi
from
San Antonio, TX
Click here to add this to my saved trials
Study to Assess the Efficacy, Safety, and Tolerability of ADL5747 in Participants With Postherpetic Neuralgia
A Phase 2A, Randomized, Blinded, Placebo- and Active-controlled, 2-Period Crossover Study to Assess the Analgesic Efficacy, Safety, and Tolerability of ADL5747 in Subjects With Postherpetic Neuralgia
Status: Enrolling
Updated:  7/8/2015
mi
from
West Palm Beach, FL
Study to Assess the Efficacy, Safety, and Tolerability of ADL5747 in Participants With Postherpetic Neuralgia
A Phase 2A, Randomized, Blinded, Placebo- and Active-controlled, 2-Period Crossover Study to Assess the Analgesic Efficacy, Safety, and Tolerability of ADL5747 in Subjects With Postherpetic Neuralgia
Status: Enrolling
Updated: 7/8/2015
Laszlo J. Mate, MD
mi
from
West Palm Beach, FL
Click here to add this to my saved trials
mi
from
Boulder, CO
Clinical Research Facility
mi
from
Boulder, CO
Click here to add this to my saved trials
mi
from
Vienna,
mi
from
Vienna,
Click here to add this to my saved trials
Crossover Post-herpetic Neuralgia (PHN)
A Randomized, Multicenter, Double-blind, Placebo-controlled, Cross-over Study of the Efficacy and Safety of BMS-954561 in Patients With Post-herpetic Neuralgia (PHN)
Status: Enrolling
Updated:  11/6/2015
mi
from
Phoenix, AZ
Crossover Post-herpetic Neuralgia (PHN)
A Randomized, Multicenter, Double-blind, Placebo-controlled, Cross-over Study of the Efficacy and Safety of BMS-954561 in Patients With Post-herpetic Neuralgia (PHN)
Status: Enrolling
Updated: 11/6/2015
Arizona Research Center
mi
from
Phoenix, AZ
Click here to add this to my saved trials
Crossover Post-herpetic Neuralgia (PHN)
A Randomized, Multicenter, Double-blind, Placebo-controlled, Cross-over Study of the Efficacy and Safety of BMS-954561 in Patients With Post-herpetic Neuralgia (PHN)
Status: Enrolling
Updated:  11/6/2015
mi
from
Lomita, CA
Crossover Post-herpetic Neuralgia (PHN)
A Randomized, Multicenter, Double-blind, Placebo-controlled, Cross-over Study of the Efficacy and Safety of BMS-954561 in Patients With Post-herpetic Neuralgia (PHN)
Status: Enrolling
Updated: 11/6/2015
Torrance Clinical Research
mi
from
Lomita, CA
Click here to add this to my saved trials
Crossover Post-herpetic Neuralgia (PHN)
A Randomized, Multicenter, Double-blind, Placebo-controlled, Cross-over Study of the Efficacy and Safety of BMS-954561 in Patients With Post-herpetic Neuralgia (PHN)
Status: Enrolling
Updated:  11/6/2015
mi
from
Ocala, FL
Crossover Post-herpetic Neuralgia (PHN)
A Randomized, Multicenter, Double-blind, Placebo-controlled, Cross-over Study of the Efficacy and Safety of BMS-954561 in Patients With Post-herpetic Neuralgia (PHN)
Status: Enrolling
Updated: 11/6/2015
Renstar Medical Research
mi
from
Ocala, FL
Click here to add this to my saved trials
Crossover Post-herpetic Neuralgia (PHN)
A Randomized, Multicenter, Double-blind, Placebo-controlled, Cross-over Study of the Efficacy and Safety of BMS-954561 in Patients With Post-herpetic Neuralgia (PHN)
Status: Enrolling
Updated:  11/6/2015
mi
from
Orlando, FL
Crossover Post-herpetic Neuralgia (PHN)
A Randomized, Multicenter, Double-blind, Placebo-controlled, Cross-over Study of the Efficacy and Safety of BMS-954561 in Patients With Post-herpetic Neuralgia (PHN)
Status: Enrolling
Updated: 11/6/2015
Compass Research LLC
mi
from
Orlando, FL
Click here to add this to my saved trials
Crossover Post-herpetic Neuralgia (PHN)
A Randomized, Multicenter, Double-blind, Placebo-controlled, Cross-over Study of the Efficacy and Safety of BMS-954561 in Patients With Post-herpetic Neuralgia (PHN)
Status: Enrolling
Updated:  11/6/2015
mi
from
Madisonville, KY
Crossover Post-herpetic Neuralgia (PHN)
A Randomized, Multicenter, Double-blind, Placebo-controlled, Cross-over Study of the Efficacy and Safety of BMS-954561 in Patients With Post-herpetic Neuralgia (PHN)
Status: Enrolling
Updated: 11/6/2015
Commonwealth Biomedical Research, LLC
mi
from
Madisonville, KY
Click here to add this to my saved trials
Crossover Post-herpetic Neuralgia (PHN)
A Randomized, Multicenter, Double-blind, Placebo-controlled, Cross-over Study of the Efficacy and Safety of BMS-954561 in Patients With Post-herpetic Neuralgia (PHN)
Status: Enrolling
Updated:  11/6/2015
mi
from
Rochester, NY
Crossover Post-herpetic Neuralgia (PHN)
A Randomized, Multicenter, Double-blind, Placebo-controlled, Cross-over Study of the Efficacy and Safety of BMS-954561 in Patients With Post-herpetic Neuralgia (PHN)
Status: Enrolling
Updated: 11/6/2015
Finger Lakes Clinical Research
mi
from
Rochester, NY
Click here to add this to my saved trials
Crossover Post-herpetic Neuralgia (PHN)
A Randomized, Multicenter, Double-blind, Placebo-controlled, Cross-over Study of the Efficacy and Safety of BMS-954561 in Patients With Post-herpetic Neuralgia (PHN)
Status: Enrolling
Updated:  11/6/2015
mi
from
Akron, OH
Crossover Post-herpetic Neuralgia (PHN)
A Randomized, Multicenter, Double-blind, Placebo-controlled, Cross-over Study of the Efficacy and Safety of BMS-954561 in Patients With Post-herpetic Neuralgia (PHN)
Status: Enrolling
Updated: 11/6/2015
Radiant Research, Inc.
mi
from
Akron, OH
Click here to add this to my saved trials
Crossover Post-herpetic Neuralgia (PHN)
A Randomized, Multicenter, Double-blind, Placebo-controlled, Cross-over Study of the Efficacy and Safety of BMS-954561 in Patients With Post-herpetic Neuralgia (PHN)
Status: Enrolling
Updated:  11/6/2015
mi
from
Boulder, CO
Crossover Post-herpetic Neuralgia (PHN)
A Randomized, Multicenter, Double-blind, Placebo-controlled, Cross-over Study of the Efficacy and Safety of BMS-954561 in Patients With Post-herpetic Neuralgia (PHN)
Status: Enrolling
Updated: 11/6/2015
Alpine Clinical Research Center
mi
from
Boulder, CO
Click here to add this to my saved trials
Crossover Post-herpetic Neuralgia (PHN)
A Randomized, Multicenter, Double-blind, Placebo-controlled, Cross-over Study of the Efficacy and Safety of BMS-954561 in Patients With Post-herpetic Neuralgia (PHN)
Status: Enrolling
Updated:  11/6/2015
mi
from
Delray Beach, FL
Crossover Post-herpetic Neuralgia (PHN)
A Randomized, Multicenter, Double-blind, Placebo-controlled, Cross-over Study of the Efficacy and Safety of BMS-954561 in Patients With Post-herpetic Neuralgia (PHN)
Status: Enrolling
Updated: 11/6/2015
Brain Matters Research
mi
from
Delray Beach, FL
Click here to add this to my saved trials
Crossover Post-herpetic Neuralgia (PHN)
A Randomized, Multicenter, Double-blind, Placebo-controlled, Cross-over Study of the Efficacy and Safety of BMS-954561 in Patients With Post-herpetic Neuralgia (PHN)
Status: Enrolling
Updated:  11/6/2015
mi
from
St Petersburg, FL
Crossover Post-herpetic Neuralgia (PHN)
A Randomized, Multicenter, Double-blind, Placebo-controlled, Cross-over Study of the Efficacy and Safety of BMS-954561 in Patients With Post-herpetic Neuralgia (PHN)
Status: Enrolling
Updated: 11/6/2015
Comprehensive Clinical Development, Inc.
mi
from
St Petersburg, FL
Click here to add this to my saved trials
Crossover Post-herpetic Neuralgia (PHN)
A Randomized, Multicenter, Double-blind, Placebo-controlled, Cross-over Study of the Efficacy and Safety of BMS-954561 in Patients With Post-herpetic Neuralgia (PHN)
Status: Enrolling
Updated:  11/6/2015
mi
from
Marietta, GA
Crossover Post-herpetic Neuralgia (PHN)
A Randomized, Multicenter, Double-blind, Placebo-controlled, Cross-over Study of the Efficacy and Safety of BMS-954561 in Patients With Post-herpetic Neuralgia (PHN)
Status: Enrolling
Updated: 11/6/2015
Drug Studies America
mi
from
Marietta, GA
Click here to add this to my saved trials
Crossover Post-herpetic Neuralgia (PHN)
A Randomized, Multicenter, Double-blind, Placebo-controlled, Cross-over Study of the Efficacy and Safety of BMS-954561 in Patients With Post-herpetic Neuralgia (PHN)
Status: Enrolling
Updated:  11/6/2015
mi
from
Natick, MA
Crossover Post-herpetic Neuralgia (PHN)
A Randomized, Multicenter, Double-blind, Placebo-controlled, Cross-over Study of the Efficacy and Safety of BMS-954561 in Patients With Post-herpetic Neuralgia (PHN)
Status: Enrolling
Updated: 11/6/2015
Analgesic Solutions
mi
from
Natick, MA
Click here to add this to my saved trials
Crossover Post-herpetic Neuralgia (PHN)
A Randomized, Multicenter, Double-blind, Placebo-controlled, Cross-over Study of the Efficacy and Safety of BMS-954561 in Patients With Post-herpetic Neuralgia (PHN)
Status: Enrolling
Updated:  11/6/2015
mi
from
Farmington Hills, MI
Crossover Post-herpetic Neuralgia (PHN)
A Randomized, Multicenter, Double-blind, Placebo-controlled, Cross-over Study of the Efficacy and Safety of BMS-954561 in Patients With Post-herpetic Neuralgia (PHN)
Status: Enrolling
Updated: 11/6/2015
QUEST Research Institute
mi
from
Farmington Hills, MI
Click here to add this to my saved trials
Crossover Post-herpetic Neuralgia (PHN)
A Randomized, Multicenter, Double-blind, Placebo-controlled, Cross-over Study of the Efficacy and Safety of BMS-954561 in Patients With Post-herpetic Neuralgia (PHN)
Status: Enrolling
Updated:  11/6/2015
mi
from
Kansas City, MO
Crossover Post-herpetic Neuralgia (PHN)
A Randomized, Multicenter, Double-blind, Placebo-controlled, Cross-over Study of the Efficacy and Safety of BMS-954561 in Patients With Post-herpetic Neuralgia (PHN)
Status: Enrolling
Updated: 11/6/2015
The Center for Pharmaceutical Research, P.C.
mi
from
Kansas City, MO
Click here to add this to my saved trials
Crossover Post-herpetic Neuralgia (PHN)
A Randomized, Multicenter, Double-blind, Placebo-controlled, Cross-over Study of the Efficacy and Safety of BMS-954561 in Patients With Post-herpetic Neuralgia (PHN)
Status: Enrolling
Updated:  11/6/2015
mi
from
St. Louis, MO
Crossover Post-herpetic Neuralgia (PHN)
A Randomized, Multicenter, Double-blind, Placebo-controlled, Cross-over Study of the Efficacy and Safety of BMS-954561 in Patients With Post-herpetic Neuralgia (PHN)
Status: Enrolling
Updated: 11/6/2015
Medex Healthcare Research, Inc
mi
from
St. Louis, MO
Click here to add this to my saved trials
Crossover Post-herpetic Neuralgia (PHN)
A Randomized, Multicenter, Double-blind, Placebo-controlled, Cross-over Study of the Efficacy and Safety of BMS-954561 in Patients With Post-herpetic Neuralgia (PHN)
Status: Enrolling
Updated:  11/6/2015
mi
from
Raleigh, NC
Crossover Post-herpetic Neuralgia (PHN)
A Randomized, Multicenter, Double-blind, Placebo-controlled, Cross-over Study of the Efficacy and Safety of BMS-954561 in Patients With Post-herpetic Neuralgia (PHN)
Status: Enrolling
Updated: 11/6/2015
Wake Research Associates, LLC
mi
from
Raleigh, NC
Click here to add this to my saved trials
Crossover Post-herpetic Neuralgia (PHN)
A Randomized, Multicenter, Double-blind, Placebo-controlled, Cross-over Study of the Efficacy and Safety of BMS-954561 in Patients With Post-herpetic Neuralgia (PHN)
Status: Enrolling
Updated:  11/6/2015
mi
from
Winston-Salem, NC
Crossover Post-herpetic Neuralgia (PHN)
A Randomized, Multicenter, Double-blind, Placebo-controlled, Cross-over Study of the Efficacy and Safety of BMS-954561 in Patients With Post-herpetic Neuralgia (PHN)
Status: Enrolling
Updated: 11/6/2015
PMG Research of Winston-Salem
mi
from
Winston-Salem, NC
Click here to add this to my saved trials
Crossover Post-herpetic Neuralgia (PHN)
A Randomized, Multicenter, Double-blind, Placebo-controlled, Cross-over Study of the Efficacy and Safety of BMS-954561 in Patients With Post-herpetic Neuralgia (PHN)
Status: Enrolling
Updated:  11/6/2015
mi
from
Oklahoma City, OK
Crossover Post-herpetic Neuralgia (PHN)
A Randomized, Multicenter, Double-blind, Placebo-controlled, Cross-over Study of the Efficacy and Safety of BMS-954561 in Patients With Post-herpetic Neuralgia (PHN)
Status: Enrolling
Updated: 11/6/2015
COR Clinical Research
mi
from
Oklahoma City, OK
Click here to add this to my saved trials
Crossover Post-herpetic Neuralgia (PHN)
A Randomized, Multicenter, Double-blind, Placebo-controlled, Cross-over Study of the Efficacy and Safety of BMS-954561 in Patients With Post-herpetic Neuralgia (PHN)
Status: Enrolling
Updated:  11/6/2015
mi
from
Austin, TX
Crossover Post-herpetic Neuralgia (PHN)
A Randomized, Multicenter, Double-blind, Placebo-controlled, Cross-over Study of the Efficacy and Safety of BMS-954561 in Patients With Post-herpetic Neuralgia (PHN)
Status: Enrolling
Updated: 11/6/2015
FutureSearch Trials of Neurology
mi
from
Austin, TX
Click here to add this to my saved trials